Global Parkinson s Disease Drug Forecast Report 2021-2029, Featuring Teva, Roche, Prothena, UCB, AbbVie and Norvartis
April 27, 2021 06:28 ET | Source: Research and Markets Research and Markets Dublin, IRELAND
ResearchAndMarkets.com s offering.
The global PD market is forecast to experience significant growth during the forecast period; global sales are expected to increase from $3.5B in 2019 to $11.5B in 2029, at a Compound Annual Growth Rate (CAGR) of 12.6%. This growth will be driven by the launch of 17 late-stage pipeline products.
The highest selling drugs are expected to be: Roche/Prothena s PRX-002 followed by Novo Nordisk s Victoza. PRX-002 is a mAb with disease-modifying properties. KOLs were optimistic about this drug and suggested it may revolutionize PD treatment. Also, the MOA of Victoza was highly regarded as a potential neuroprotective drug in addition to its established high safety profile.
Global Parkinson's Disease Drug Forecast and Market Analysis to 2029: High Opportunities and High Risks for Disease-Modifying Therapies Entering the PD Market yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Kansas City Southern (NYSE: KSU)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
Kansas City Southern (NYSE: KSU) in connection with the proposed acquisition of the company by Canadian Pacific Railway Limited ( Canadian Pacific ). Under the terms of the agreement, KSU shareholders will receive $90.00 in cash and 0.489 of a share of Canadian Pacific stock for each KSU share that they hold, representing implied per-share merger consideration of approximately $268.67 based upon Canadian Pacific s April 19, 2021 closing price of $365.37. If you own KSU shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/ksu/
Share this article
LAS VEGAS, April 14, 2021 /PRNewswire/ DelveInsight s
Parkinson s Disease Market report provides a thorough comprehension of the Parkinson s Disease, historical and forecasted epidemiology, and the Parkinson s Disease market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Parkinson s Disease market report also proffers an analysis of the current Parkinson s Disease treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
Key takeaways of the
The increase in Parkinson s disease prevalent population in the 7MM and the expected entry of premium price assets will influence market size growth.
SHAREHOLDER ALERT: WeissLaw LLP Reminds KSU, SNX, SPRT, and NTEC Shareholders About Its Ongoing Investigations yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.